Domov › Rak mehurja › North Carolina › Durham
Klinične študije za Rak mehurja v Durham, NC
20 študij za Rak mehurja išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- in še 1
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Vključevanje udeležencevFaza 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Vključevanje udeležencevFaza 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Vključevanje udeležencevOpazovalna študija
- UNC- Chapel Hill, Chapel Hill · 10 mi stran
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi stran
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Vključevanje udeležencevFaza 2/3
- Research Site, Chapel Hill · 10 mi stran
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Vključevanje udeležencevFaza 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 mi stran
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Vključevanje udeležencevOpazovalna študija
- University of North Carolina, Chapel Hill · 10 mi stran
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Vključevanje udeležencevFaza 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 mi stran
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Vključevanje udeležencev
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi stran
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Vključevanje udeležencevOpazovalna študija
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi stran
Študije za Rak mehurja v drugih mestih
- New York City, NY35 študij
- Nashville, TN31 študij
- Houston, TX31 študij
- Dallas, TX27 študij
- Boston, MA26 študij
- Washington, DC26 študij
- Los Angeles, CA24 študij
- Baltimore, MD24 študij
- St. Louis, MO22 študij
- Philadelphia, PA21 študij
- Seattle, WA21 študij
- Edison, NJ21 študij
Druge študije v Durham
- Rak dojke63 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Metastatski rak33 študij
- Akutna mieločna levkemija33 študij
- Rak pljuč32 študij
- Rak prostate32 študij
- Kolorektalni rak28 študij
- Kronična limfocitna levkemija27 študij
- Rak jajčnikov27 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.